- Home
- BIDU vs RGC Comparison
BIDU vs RGC Comparison
Compare BIDU & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIDU | RGC |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | China | Hong Kong |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7B | 8.4B |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BIDU | RGC |
|---|---|---|
| Price | $124.75 | $17.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $144.23 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 210.3K |
| Earning Date | 11-18-2025 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.25 | N/A |
| Revenue | ★ $18,325,514,127.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | $38.49 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $74.71 | $0.09 |
| 52 Week High | $149.51 | $83.60 |
Technical Indicators
Market Signals| Indicator | BIDU | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 53.75 | 64.34 |
| Support Level | $123.48 | $16.10 |
| Resistance Level | $131.24 | $17.40 |
| Average True Range (ATR) | 3.04 | 1.62 |
| MACD | 1.11 | 0.63 |
| Stochastic Oscillator | 64.91 | 88.24 |
Price Performance
Historical ComparisonAbout BIDU Baidu Inc. ADS
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 70% of core revenue from online marketing services from its search engine in 2024. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.